Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 May;148(5):628-632.
doi: 10.1016/j.jpeds.2006.01.011.

Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome

Affiliations
Comparative Study

Growth, motor, and social development in breast- and formula-fed infants of metformin-treated women with polycystic ovary syndrome

Charles J Glueck et al. J Pediatr. 2006 May.

Abstract

Objectives: To test the hypothesis that metformin during lactation versus formula feeding would have no adverse effects on infants' growth, motor-social development, or intercurrent illness.

Study design: Growth, motor-social development, and illness requiring a pediatrician visit were assessed in 61 nursing infants (21 male, 40 female) and 50 formula-fed infants (19 male, 31 female) born to 92 mothers with polycystic ovary syndrome (PCOS) taking a median of 2.55 g metformin per day throughout pregnancy and lactation.

Results: Within sex, at 3 and 6 months of age, weight, height, and motor-social development did not differ (p > or = .06) between breast- and formula-fed infants. No infants had retardation of growth, motor, or social development. Intercurrent illnesses did not differ.

Conclusions: Metformin during lactation appears to be safe and effective in the first 6 months of infancy.

PubMed Disclaimer

Comment in

Publication types